Business
HLS Therapeutics Announces Update on Health Canada Filings for MyCare and Trinomia
HLS Therapeutics Announces Update on Health Canada Filings for MyCare and Trinomia ...
About this update from Hls Therapeutics, Inc.
[{"type":"text","content":"\n \n \n \n HLS Therapeutics Announces Update on Health Canada Filings for MyCare and Trinomia\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n \n \n Health\n \n Canada\n \n approves MyCare Psychiatry Lab Assays for use in diagnostic lab settings to measure blood levels in patients prescribed six of the most common antipsychotic drugs\n \n \n \n \n \n \n MyCare Insite point-of-care (POC) device, which measures the level of antipsychotic drugs in patients' blood, is under review and could be approved in H1-2021\n \n \n \n \n \n \n Health\n \n Canada\n \n issued a Notice of Deficiency for Trinomia\n \n \n \n \n \n \n \n \n TORONTO\n \n ,\n \n Dec. 16, 2020\n \n /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX:HLS), a specialty pharmaceutical company focusing on central nervous system and cardiovascular markets, announces updates on its filings with Health Canada for MyCare and Trinomia.\n \n \n The Company is pleased to report that Health Canada has approved five MyCare™ Psychiatry Lab Assay diagnostic tests from Saladax Biomedical, Inc. (\"Saladax\") for use in measuring blood levels in patients taking any of the six most common antipsychotic drugs. HLS is the exclusive distributor of these products in\n \n Canada\n \n . Regarding Trinomia, a polypill of three common medications that is intended for secondary cardiovascular prevention, Health Canada issued a Notice of Deficiency (\"NOD\") indicating that additional scientific data may be required for approval.\n \n \n \n \n MYCARE LAB ASSAYS AND MYCARE INSITE\n \n \n \n The approved\n \n MyCare Psychiatry Lab Assays\n \n are diagnostic tools that can be used on most large high-speed lab analyzers. They allow for the measuring and monitoring of blood drug concentration levels of clozapine, risperidone, paliperidone, aripiprazole, olanzapine, and quetiapine. For the first time, the timely monitoring of those hematological parameters is possible, and this diagnostic capability is considered an important step towards optimizing therapy for patients who are taking those medications.\n \n 1...